Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Eli Lilly And Co. (LLY)
Eli Lilly Says Omvoh-Treated Patients Sustained Disease Clearance In Ulcerative Colitis At 4 Years
5/5/2026 8:01:18 AM
Eli Lilly Says Omvoh Demonstrates Durable Disease Clearance In Long-Term UC Study
5/5/2026 6:50:33 AM
Lilly Declares Quarterly Dividend Of $1.73/share, Payable June 10/ Record May 15
5/4/2026 11:33:09 AM
Eli Lilly Stock Jumps 9% On Strong Q1 Results, Raises FY26 Outlook
4/30/2026 10:33:40 AM
Weekly Buzz: FDA Okays Saphnelo Pen, EC Clears Acromegaly Drug, SNGX Slumps, LGND Snaps Up XOMA
4/30/2026 9:47:31 AM
Eli Lilly Boosts FY26 Outlook; Stock Up 5.3% - Update
4/30/2026 7:08:41 AM
Eli Lilly And Co. Bottom Line Climbs In Q1
4/30/2026 6:53:58 AM
Lilly Q1 Non-GAAP Net Income Rises To $7.7 Bln Or $8.55/shr From $3.0 Bln Or $3.34/shr Last Year
4/30/2026 6:48:28 AM
Eli Lilly And Co Q1 26 Earnings Conference Call At 10:00 AM ET
4/30/2026 6:02:31 AM
Profluent Inks Up To $2.25 Bln Deal With Lilly For Genetic Medicines
4/28/2026 8:55:55 AM
Profluent, Lilly Announce $2.25 Bln Partnership To Advance AI-Designed Genetic Medicine Tools
4/28/2026 8:10:28 AM
Lilly Acquires Ajax Therapeutics For Blood Cancer Pipeline
4/27/2026 8:22:13 AM
Eli Lilly To Buy Ajax Therapeutics To Advance AJ1-11095 Development
4/27/2026 7:19:29 AM
Lilly Agewws To Acquire Ajax Therapeutics
4/27/2026 6:50:24 AM
Weekly Buzz: SNY, REGN Get FDA Nod; It's A No For ABBV, GRCE; LLY Acquires Kelonia
4/24/2026 10:34:13 AM
Lilly To Acquire Kelonia Therapeutics To Advance In Vivo CAR-T Cell Therapies
4/20/2026 10:39:37 AM
Lilly Agrees To Acquire Kelonia Therapeutics For Up To $7 Bln
4/20/2026 9:35:49 AM
Lilly To Acquire Kelonia Therapeutics In Deal Worth Up To $7 Bln
4/20/2026 9:03:27 AM
Lilly In Advanced Talks To Acquire Kelonia Therapeutics For More Than $2 Bln : Report
4/19/2026 11:32:13 PM
Weekly Buzz: FDA Okays TVTX, PHG; Rejects REPL; AIP Snaps Up AVNS; PDS, HOTH, SYRE, Paces Trials
4/17/2026 10:38:28 AM
1
2
3
4
Next
»